-
IWP-2 Workflow for Wnt Production Inhibition
2026-09-01
IWP-2 provides an upstream way to suppress Porcupine-dependent Wnt secretion, helping researchers connect pathway blockade with proliferation, invasion, apoptosis, and cell morphology. This practical guide combines product handling, a gastric cancer workflow, and high-content profiling principles inspired by a cardiomyopathy study.
-
Parthenolide, ROS, and Apoptosis in Lymphoid Malignancies
2026-08-31
Jorge and colleagues show that parthenolide reduces metabolic activity and promotes oxidative-stress-associated apoptosis across diverse lymphoid malignancy models, while the detailed mechanism varies by cell line. The study is valuable because it combines a resazurin-based cell viability assay with flow-cytometric and transcriptional measurements to connect reduced metabolic activity with ROS accumulation, glutathione loss, mitochondrial depolarization, and apoptotic signaling.
-
Betaine Hydrochloride in Inflammation Assays
2026-08-31
Explore how Betaine hydrochloride can support controlled metabolic enzyme, protease, cell culture, and molecular biology workflows without being confused with an anti-inflammatory treatment. This article translates a recent esophageal cancer study into practical assay-design decisions, controls, and limitations.
-
Regorafenib, RRM2, and Melanoma Progression
2026-08-30
The 2024 iScience study identifies RRM2 as a mechanistically important downstream effector of regorafenib in melanoma. By combining phenotypic assays, RNA sequencing, perturbation and rescue experiments, and xenograft validation, the work connects multikinase inhibition with ERK/E2F3-associated control of melanoma growth, invasion, and apoptosis.
-
Polybrene for Viral Delivery and p53 Assays
2026-08-29
Polybrene (Hexadimethrine Bromide) improves viral attachment and uptake while supporting difficult lipid-mediated DNA transfection workflows. This practical guide shows how to use it as a delivery aid for mutant-p53 assay development without confusing transduction enhancement with direct p53 reactivation.
-
Diminazene Aceturate: Research Workflows
2026-08-28
Diminazene Aceturate supports two distinct research tracks: trypanocidal screening in parasite models and pathway-oriented ACE2 activation research. This guide translates its formulation data and recent cardiac-injury findings into practical workflows, controls, and troubleshooting strategies.
-
25-Hydroxycholesterol, AMPK, and TAM Reprogramming
2026-08-28
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that connects lysosomal cholesterol handling with AMPKα–STAT6 signaling in tumor-associated macrophages. Their findings explain how macrophages acquire immunosuppressive properties and suggest that CH25H targeting may improve T-cell surveillance and anti-PD-1 responses.
-
Direct Mouse Genotyping Kit: PCR Workflow
2026-08-28
The Direct Mouse Genotyping Kit supports rapid genomic DNA release and PCR amplification directly from mouse tissue lysates, avoiding conventional DNA purification for routine mouse genetic screening. It is intended for PCR-based genotyping and high-throughput workflows, not for applications requiring ultra-pure DNA or downstream enzymatic assays beyond PCR.
-
A-1155463: Mapping BCL-XL Apoptotic Dependence
2026-08-27
The BCL-XL inhibitor A-1155463 offers a precise way to test mitochondrial apoptosis dependence in resistant cancer models. This article translates glioblastoma findings into experimentally useful decisions about cell state, apoptotic priming, assay endpoints, and preclinical interpretation.
-
GSK J4 HCl: JMJD3 Inhibitor Workflows
2026-08-26
GSK J4 HCl converts JMJD3 biology into practical assays for chromatin, inflammation, and cancer research. Its intracellular conversion to GSK J1 supports cell-based experiments that connect H3K27 demethylation with cytokine output, promoter occupancy, and tumor-model phenotypes.
-
Isradipine (Dynacirc): A Calcium Attribution Guide
2026-08-26
Isradipine and Dynacirc are examined here through a channel-attribution framework rather than a conventional product workflow. Learn how L-type pharmacology, neuronal calcium-channel heterogeneity, and assay controls shape rigorous hypertension and neuroprotection research.
-
BFH772 (VEGFR2 inhibitor): Workflow Guide
2026-08-26
BFH772 is a selective VEGFR2 kinase inhibitor for experiments that require controlled modulation of VEGFR2-mediated angiogenic signaling. Its organic-solvent solubility and water insolubility make it suitable for biochemical, cellular, and tumor-model workflows with validated vehicle controls, but unsuitable for protocols requiring aqueous dosing or broad-spectrum kinase inhibition.
-
Angiotensin I: Applied Assay Workflows
2026-08-25
Turn Angiotensin I into a controllable probe for renin-angiotensin system research, ACE activity studies, antihypertensive drug screening, and neuroendocrine models. This guide combines peptide handling, conversion-assay design, fluorescence-data safeguards, and troubleshooting for more interpretable results.
-
SepM Mutations and S. mutans–S. gordonii Inhibition
2026-08-24
Liu et al. linked recurrent sepM missense mutations in clinical Streptococcus mutans isolates with stronger inhibition of Streptococcus gordonii and investigated how selected substitutions alter SepM–CSP-21 binding. The study connects bacterial genotype, ComDE signaling, protein structure, and pH-dependent ligand affinity, while also defining important limits for interpreting these findings in oral biofilm biology.
-
Acetylcysteine: Mechanism and Research Use
2026-08-24
Acetylcysteine, also called N-acetyl-L-cysteine or NAC, is a cysteine source for glutathione biosynthesis and a direct thiol-based redox reagent. Its research value spans oxidative stress pathway modulation, hepatic protection research, respiratory disease models, and Huntington’s disease research, but experimental effects remain concentration-, cell-, and model-dependent.
450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page